
Gland Pharma Limited has informed the Exchange regarding a press release dated December 03, 2024, titled "Gland Pharma receives approval for Latanoprost Ophthalmic Solution".
Filed with NSE ·

Gland Pharma Limited has informed the Exchange regarding a press release dated December 03, 2024, titled "Gland Pharma receives approval for Latanoprost Ophthalmic Solution".
6ix hasn’t read this filing yet.
Follow Gland Pharma into a list and get an email when it puts out news.
Follow Gland Pharma